The results showed that the average frequency of cells with demethylated FOXP3 in normal tissues was significantly lower than that in tumor tissues from both patients with colorectal cancer (CRC) and intrahepatic cholangiocarcinoma (ICC) rats. This evidence concerns the gene FOXP3 and colorectal carcinoma.